Frances J. Hayes, MB BCh BAO - Program Chair
Associate Clinical Chief of Endocrinology
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School
John D. Carmichael, MD
Co-Director, USC Pituitary Center
Associate Professor of Clinical Medicine
Division of Endocrinology, Diabetes and Metabolism
Keck School of Medicine of University of Southern California
Natalie Cusano, MD, MS
Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital
Tobias Else, MD
Associate Professor
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan
Jacqueline Jonklaas, MD, PhD, MPH
Professor
Division of Endocrinology
Georgetown University Medical Center
Sangeeta R. Kashyap, MD
Assistant Chief of Clinical Affairs
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine New York Presbyterian
Margaret Flynn Lippincott, MD
Assistant Professor of Medicine
Harvard Medical School
Physician Investigator
Reproductive Endocrine Unit
Massachusetts General Hospital
Marie E. McDonnell, MD
Section Chief, Diabetes Section
Division of Endocrinology Diabetes and Hypertension
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School
Stephanie T. Page, MD, PhD
Robert B. McMillen Professor of Medicine in Lipid Research
Division Head, Metabolism, Endocrinology and Nutrition
Co-Director, UW Medicine Diabetes Institute
University of Washington
Anne L. Peters, MD
Professor of Clinical Medicine
Keck School of Medicine of University of Southern California
STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships:
John D. Carmichael, MD, Novo Nordisk: Advisory Board Member; Recordati: Advisory Board Member; Camurus: Advisory Board Member
Natalie Cusano, MD, MS, Takeda/Shire: Research Funds; Ascendis Pharma: Consultant; Alexion: Speaker
Tobias Else, MD, Corcept Pharmaceuticals: Co-Investigator; Merck: Advisor Board Member, Co-Investigator; Lantheus: Advisory Board Member; VHL Alliance: Committee Member
Sangeeta Kashyap, MD, GI Dynamics: Investigator, Consultant; Fractyl: Research Support; Gila Therapeutics: Chief Medical Officer
Marie E. McDonnell, MD, Eisai: Trial Event Adjudicator; Lilly, Inc.: Research Grant
Stephanie Page, MD, PhD, UpToDate: Editor
Anne Peters, MD, Abbot Diabetes Care: Advisory Board Member, Research Support; Medscape: Advisory Board Member; Novo Nordisk: Advisory Board Member; Vertex: Advisory Board Member; Zealand: Advisory Board Member; Blue Circle Health: Consultant; Dexcom: Research Support; Insulet: Research Support; Omada Health: Stock Options; Teladoc: Stock Options
The following faculty reported no relevant financial relationships: Frances J. Hayes, MB BCh BAO; Jacqueline Jonklaas, MD, PhD, MPH; and Margaret Flynn Lippincott, MD
The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)
Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The activity is not supported by educational grant(s) or other funds from any commercial supporters.